Endothelin-1 and L-Arginine in Preterm Infants with Respiratory Distress

ABSTRACT

In addition to the immaturity of air sacs and surfactant deficiency, preterm infants with respiratory distress syndrome (RDS) have abnormalities in the pulmonary vascular bed. We aimed to study two known modulators of pulmonary vessels: endothelin-1 (ET-1) and L-arginine. We hypothesized that plasma concentrations of ET-1 and L-arginine could correlate with the severity of RDS. We prospectively studied 71 preterm infants (gestational age = 29 to 35 weeks) with and without RDS. We measured plasma ET-1 by enzyme-linked immunosorbent assay and L-arginine by spectrophotometry. Infants who continued to require oxygen support or died by day of life 28 were considered to have bronchopulmonary dysplasia (BPD). ET-1 concentrations were significantly higher in RDS infants (p = 0.039) than controls. Among infants with RDS, it was significantly higher in those who later developed BPD (p = 0.026). L-arginine was significantly lower in RDS infants (p = 0.001), but did not differ between BPD and non-BPD infants (p = 0.19). There was no correlation between L-arginine and ET-1 (r = 0.1, p = 0.41). The acute phase of RDS is associated with increased plasma concentrations of ET-1 and decreased L-arginine. Infants who later developed BPD had higher plasma ET-1 at birth. Concentrations of ET-1 and L-arginine did not correlate.

KEYWORDS

Pulmonary vessels - nitric oxide - NO - surfactant - BPD - premature

REFERENCES

• 1 Warren J B, Anderson J DM. Core concepts: respiratory distress syndrome.  Neoreviews. 2009;  10 351-361
• 2 Jobe A H. The new BPD.  Neoreviews. 2006;  7 e531-e545
• 3 Ersch J, Roth-Kleiner M, Baeckert P, Bucher H U. Increasing incidence of respiratory distress in neonates.  Acta Paediatr. 2007;  96 1577-1581
• 4 Escobedo M B, Gunkel J H, Kennedy K A Texas Neonatal Research Group et al. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial.  J Pediatr. 2004;  144 804-808
• 5 Teksam O, Kale G. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.  Pathol Res Pract. 2009;  205 35-41
• 6 Ballard R A, Truog W E, Cnaan A NO CLD Study Group et al. Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.  N Engl J Med. 2006;  355 343-353
• 7 Yanagisawa M, Kurihara H, Kimura S et al.. A novel potent vasoconstrictor peptide produced by vascular endothelial cells.  Nature. 1988;  332 411-415
• 8 Springall D R, Howarth P H, Counihan H, Djukanovic R, Holgate S T, Polak J M. Endothelin immunoreactivity of airway epithelium in asthmatic patients.  Lancet. 1991;  337 697-701
• 9 Chanez P, Vignola A M, Albat B et al.. Involvement of endothelin in mononuclear phagocyte inflammation in asthma.  J Allergy Clin Immunol. 1996;  98 412-420
• 10 Kojima T, Hattori K, Hirata Y et al.. Endothelin-1 has a priming effect on production of superoxide anion by alveolar macrophages: its possible correlation with bronchopulmonary dysplasia.  Pediatr Res. 1996;  39 112-116
• 11 Medbø S, Tølløfsrud P A, Saugstad O D. Pulmonary hemodynamics in newborn piglets during hypoxemia and reoxygenation: blocking of the endothelin-1 receptors.  Pediatr Res. 1999;  46 514-522
• 12 Yigit S, Tekinalp G, Oran O, Yurdakok M, Aliefendioglu D, Gurgey A. Endothelin 1 concentrations in infants with meconium stained amniotic fluid.  Arch Dis Child Fetal Neonatal Ed. 2002;  87 F212-F213
• 13 Moncada S, Higgs A. The L-arginine-nitric oxide pathway.  N Engl J Med. 1993;  329 2002-2012
• 14 Yang Z, Kaye D M. Endothelial dysfunction and impaired L-arginine transport in hypertension and genetically predisposed normotensive subjects.  Trends Cardiovasc Med. 2006;  16 118-124
• 15 Flynn N E, Meininger C J, Haynes T E, Wu G. The metabolic basis of arginine nutrition and pharmacotherapy.  Biomed Pharmacother. 2002;  56 427-438
• 16 Canpolat F E, Yurdakök M, Yiğit S, Korkmaz A, Tekinalp G. Blood L-arginine levels in early respiratory distress syndrome.  Pediatr Pulmonol. 2005;  40 511-514
• 17 Voelkel N F, Tuder R M. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?.  J Clin Invest. 2000;  106 733-738
• 18 Olsen S L, Clark P L, Thibeault D W, Norberg M, Truog W E. Exhaled nitric oxide and tracheal endothelin-1 in preterm infants with and without RDS.  Pediatr Pulmonol. 2003;  36 421-426
• 19 Niu J O, Munshi U K, Siddiq M M, Parton L A. Early increase in endothelin-1 in tracheal aspirates of preterm infants: correlation with bronchopulmonary dysplasia.  J Pediatr. 1998;  132 965-970
• 20 Andersson S, Merritt T A, Orpana A, Viinikka L, Ylikorkala O. High endothelin-1 in the airways of preterm infants is associated with less severe respiratory distress during the early postnatal period.  Pediatrics. 1997;  99 545-547
• 21 Ballard J L, Khoury J C, Wedig K, Wang L, Eilers-Walsman B L, Lipp R. New Ballard Score, expanded to include extremely premature infants.  J Pediatr. 1991;  119 417-423
• 22 Downes J J, Vidyasagar D, Boggs Jr T R, Morrow III G M. Respiratory distress syndrome of newborn infants. I. New clinical scoring system (RDS score) with acid—base and blood-gas correlations.  Clin Pediatr (Phila). 1970;  9 325-331
• 23 Cleveland R H. A radiologic update on medical diseases of the newborn chest.  Pediatr Radiol. 1995;  25 631-637
• 24 Bhakta K Y. Respiratory distress syndrome. In: Cloherty J B, Eichenwald E C, Stark A R Manual of Neonatal Care, 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008: 323-330
• 25 Tsikas D. Analysis of the L-arginine /nitric oxide pathway: the unique role for mass spectrometry.  Curr Pharmaceut Anal. 2005;  1 15-30
• 26 Kuo C Y, Chou Y H, Lien R, Yang P H. Study of plasma endothelin-1 concentrations in Taiwanese neonates with respiratory distress.  Chang Gung Med J. 2001;  24 239-244
• 27 de Vroomen M, Lopes Cardozo R H, Steendijk P, Frölich M, Baan J, van Bel F. Endothelin-1 plasma concentration increases in the early phase of pulmonary hypertension development during respiratory distress syndrome: a study in newborn lambs.  Early Hum Dev. 2001;  63 9-21
• 28 Benjamin A C, Silveira R C, Procianoy R S. Umbilical cord blood and neonatal endothelin-1 levels in preterm newborns with and without respiratory distress syndrome.  Braz J Med Biol Res. 2005;  38 1417-1422
• 29 Takahashi M. The role of endothelin-1 in vascular remodeling in vivo.  Cardiovasc Res. 2006;  71 4-5
• 30 Thompson A, Bhandari V. Pulmonary biomarkers of bronchopulmonary dysplasia.  Biomark Insights. 2008;  3 361-373
• 31 Vosatka R J, Kashyap S, Trifiletti R R. Arginine deficiency accompanies persistent pulmonary hypertension of the newborn.  Biol Neonate. 1994;  66 65-70
• 32 McCaffrey M J, Bose C L, Reiter P D, Stiles A D. Effect of L-arginine infusion on infants with persistent pulmonary hypertension of the newborn.  Biol Neonate. 1995;  67 240-243
• 33 Heckmann M, Kreuder J, Riechers K et al.. Plasma arginine and urinary nitrate and nitrite excretion in bronchopulmonary dysplasia.  Biol Neonate. 2004;  85 173-178
• 34 Rodrigues R J, Martin R J, Fanaroff A. The respiratory distress syndrome and its management. In: Fanaroff A, Martin R J Neonatal Perinatal Medicine: Diseases of the Fetus and Infant. St. Louis: Mosby; 2002: 1001-1011
• 35 Kavvadia V, Greenough A, Lilley J et al.. Plasma arginine levels and the response to inhaled nitric oxide in neonates.  Biol Neonate. 1999;  76 340-347